Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV

China's CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine

A brief review on DNA vaccines in the era of COVID-19

Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete

Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages

Vaccines, Free Full-Text

Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine

Immunogenicity of a DNA vaccine candidate for COVID-19

Advancements in DNA vaccines against COVID-19